Recursion Pharmaceuticals, Inc. (RXRX)
NASDAQ: RXRX · Real-Time Price · USD
6.74
+0.10 (1.44%)
Nov 5, 2024, 3:49 PM EST - Market open
Recursion Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Nov '24 Nov 5, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Market Capitalization | 1,892 | 2,136 | 1,461 | 2,895 | - | - |
Market Cap Growth | 39.99% | 46.15% | -49.51% | - | - | - |
Enterprise Value | 1,481 | 1,800 | 1,059 | 2,317 | - | - |
Last Close Price | 6.64 | 9.86 | 7.71 | 17.13 | - | - |
PE Ratio | - | -6.25 | -5.65 | -11.51 | - | - |
PS Ratio | 30.49 | 47.92 | 36.68 | 284.42 | - | - |
PB Ratio | 3.19 | 4.61 | 3.01 | 5.33 | - | - |
P/FCF Ratio | -5.88 | -7.13 | -12.12 | -14.59 | - | - |
P/OCF Ratio | -6.07 | -7.42 | -17.50 | -18.25 | - | - |
EV/Sales Ratio | 29.84 | 40.38 | 26.58 | 227.62 | - | - |
EV/EBITDA Ratio | -4.84 | -5.53 | -4.53 | -13.29 | - | - |
EV/EBIT Ratio | -4.46 | -5.14 | -4.31 | -12.68 | - | - |
EV/FCF Ratio | -5.16 | -6.01 | -8.78 | -11.68 | - | - |
Debt / Equity Ratio | 0.15 | 0.11 | 0.10 | 0.00 | 0.05 | 0.16 |
Debt / FCF Ratio | -0.26 | -0.17 | -0.42 | 0.00 | -0.24 | -0.20 |
Asset Turnover | 0.07 | 0.07 | 0.06 | 0.02 | 0.02 | - |
Quick Ratio | 5.54 | 4.24 | 5.51 | 11.27 | 11.35 | 10.48 |
Current Ratio | 6.07 | 4.70 | 5.68 | 11.46 | 11.53 | 11.43 |
Return on Equity (ROE) | -71.18% | -69.12% | -46.56% | -47.51% | -54.57% | - |
Return on Assets (ROA) | -34.35% | -32.29% | -23.42% | -25.14% | -26.44% | - |
Return on Capital (ROIC) | -41.43% | -41.64% | -28.43% | -28.62% | -30.76% | - |
Earnings Yield | -20.10% | -15.36% | -16.39% | -6.44% | - | - |
FCF Yield | -18.34% | -14.03% | -8.25% | -6.85% | - | - |
Buyback Yield / Dilution | -20.41% | -18.41% | -40.04% | -475.48% | -0.98% | - |
Total Shareholder Return | -20.41% | -18.41% | -40.04% | -475.48% | -0.98% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.